Increased Bone Turnover in Type 2 Diabetes Patients Randomized to Bariatric Surgery Versus Medical Therapy at 5 Years
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Objective The aim of our study was to determine the 5-year outcomes of bariatric surgery versus intensive medical therapy on bone turnover in patients with type 2 diabetes mellitus (T2DM) from the STAMPEDE trial. Methods This was an ancillary investigation of a 5-year randomized control trial at a single tertiary care center involving 95 patients aged 48.5 ± 8 years with obesity (body mass index [BMI], 36.5 ± 3.6 kg/m 2 ) and uncontrolled T2DM (glycated hemoglobin 9.3 ± 1.6% [78 mmol/mol]). Patients were randomized to intensive medical therapy (IMT; n = 25), Roux-en-Y gastric bypass (RYGB; n = 37), or sleeve gastrectomy (SG; n = 33) for diabetes treatment. Bone formation marker osteocalcin (OC), bone resorption marker serum C-telopeptide of type 1 collagen (CTX), and intact parathyroid hormone (PTH) were assessed at baseline and 5 years postintervention. Analysis with key clinical parameters and outcomes (i.e., age, menopausal status, gender, weight loss) was performed. Results Percent change in CTX at 5 years increased in both surgical groups, by 137 ± 108% in RYGB ( P Conclusion In patients with T2DM, bone turnover remains chronically elevated at 5 years following RYGB, and to a lesser extent in SG patients. Abbreviations BMI = body mass index; BTM = bone turnover marker; CTX = C-telopeptide of type 1 collagen; HbA1c = glycated hemoglobin; IMT = intensive medical therapy; OC = osteocalcin; PPI = proton-pump inhibitor; PTH = parathyroid hormone; RYGB = Roux-en-Y gastric bypa…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In April 2021, the duodenal mucosal resurfacing approach was given an FDA Breakthrough Device Designation for treatment in persons with T2D, which should accelerate its development and review.791”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [791]
Citations
Cites
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Aminian, A., Brethauer, S. A., Navaneethan, S. D., Singh, R. P., Pothier, C. E., Nissen, S. E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1600869 · Cited by 2,934
Self-citationBariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
Schauer, P. R., Kashyap, S. R., Wolski, K., Brethauer, S. A., Kirwan, J. P., Pothier, C. E., Thomas, S., Abood, B., Nissen, S. E., & Bhatt, D. L. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200225 · Cited by 2,164
Self-citationMarkers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study
Garnero, P., Hausherr, E., Chapuy, M.-C., Marcelli, C., Grandjean, H., Muller, C., Cormier, C., Bréart, G., Meunier, P. J., & Dr. Delmas, P. D. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111021 · Cited by 989
Rosiglitazone-Associated Fractures in Type 2 Diabetes
Kahn, S. E., Zinman, B., Lachin, J. M., Haffner, S. M., Herman, W. H., Holman, R. R., Kravitz, B. G., Yu, D., Heise, M. A., Aftring, R. P., et al. (2008) · Diabetes Care · doi:10.2337/dc07-2270 · Cited by 537
Heber, D., Greenway, F. L., Kaplan, L. M., Livingston, E., Salvador, J., & Still, C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2128 · Cited by 521
Relationship of Bone Turnover to Bone Density and Fractures
Melton, L. J., Khosla, S., Atkinson, E. J., O'Fallon, W. M., & Riggs, B. L. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.7.1083 · Cited by 350
Yamamoto, M., Yamaguchi, T., Yamauchi, M., Kaji, H., & Sugimoto, T. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081207 · Cited by 327
Fleischer, J., Stein, E. M., Bessler, M., Badia, M. D., Restuccia, N., Olivero-Rivera, L., McMahon, D. J., & Silverberg, S. J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0481 · Cited by 278
Fracture risk following bariatric surgery: A population-based study
Nakamura, K. M., Haglind, E. G. C., Clowes, J. A., Achenbach, S. J., Atkinson, E. J., Melton, L. J., & Kennel, K. A. (2014) · Osteoporosis International · doi:10.1007/s00198-013-2463-x · Cited by 227
Change in fracture risk and fracture pattern after bariatric surgery: nested case-control study
Rousseau, C., Jean, S., Gamache, P., Lebel, S., Mac-Way, F., Biertho, L., Michou, L., & Gagnon, C. (2016) · BMJ · doi:10.1136/bmj.i3794 · Cited by 203
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Obesity and Bone: A Complex Relationship
Rinonapoli, G., Pace, V., Ruggiero, C., Ceccarini, P., Bisaccia, M., Meccariello, L., & Caraffa, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413662 · Cited by 261
Bone Health After Bariatric Surgery
Gagnon, C., & Schafer, A. L. (2018) · JBMR Plus · doi:10.1002/jbm4.10048 · Cited by 176
Long-Term Weight Loss Strategies for Obesity
Kheniser, K., Saxon, D. R., & Kashyap, S. R. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab091 · Cited by 139
“Unfortunately, there are weight loss-related negative effects on bone mineral density (BMD) and bone turnover (124,125).”
Self-citationMetabolic and Endocrine Consequences of Bariatric Surgery
Cornejo-Pareja, I. M., Clemente‐Postigo, M., & Tinahones, F. J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00626 · Cited by 145
“Amore noticeable effect was seen after RYGB than in SG (288).”
Background
Metadata
- Authors
- Crawford, M. R., Pham, N. N., Khan, L. A., Bena, J. F., Schauer, P. R., & Kashyap, S. R.
- Affiliations
- Cleveland Clinic (US)
- Case Western Reserve University (US)
- Corresponding author
- Kashyap, Sangeeta R.
- Venue
- Endocrine Practice
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 24
- Issue
- 3
- Pages
- 256-264
- ISSN
- 1530-891X (ISSN-L)
- OpenAlex
- W2769334349
- Cited by
- 54
- References
- 40
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 7 · 2021: 10 · 2020: 12 · 2019: 12 · 2018: 2
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Endocrine Practice (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK089547)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- type 2 diabetes, bariatric surgery, Roux-en-Y gastric bypass, sleeve gastrectomy, bone turnover markers, osteocalcin, parathyroid hormone, intensive medical therapy, long-term outcomes, body mass index, weight loss, STAMPEDE trial, osteoporosis risk, HbA1c
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Male, Middle Aged, Obesity, Bone Remodeling, Treatment Outcome, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased Bone Turnover in Type 2 Diabetes Patients Randomized to Bariatric Surgery Versus Medical Therapy at 5 Years. https://app.cochat.ai/papers/10.4158/ep-2017-0072
- The paper
- Crawford, M. R., Pham, N. N., Khan, L. A., Bena, J. F., Schauer, P. R., & Kashyap, S. R. (2018). Increased Bone Turnover in Type 2 Diabetes Patients Randomized to Bariatric Surgery Versus Medical Therapy at 5 Years. Endocrine Practice. https://doi.org/10.4158/ep-2017-0072
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.